Abstract:BackgroundIn humans, Mammalian Target of Rapamycin (MTOR) encodes a 300 kDa serine/ threonine protein kinase that is ubiquitously expressed, particularly at high levels in brain. MTOR functions as an integrator of multiple cellular processes, and in so doing either directly or indirectly regulates the phosphorylation of at least 800 proteins. While somatic MTOR mutations have been recognized in tumors for many years, and more recently in hemimegalencephaly, germline MTOR mutations have rarely been described.Case presentationWe report the successful application of family-trio Diagnostic Exome Sequencing (DES) to identify the underlying molecular etiology in two brothers with multiple neurological and developmental lesions, and for whom previous testing was non-diagnostic. The affected brothers, who were 6 and 23 years of age at the time of DES, presented symptoms including but not limited to mild Autism Spectrum Disorder (ASD), megalencephaly, gross motor skill delay, cryptorchidism and bilateral iris coloboma. Importantly, we determined that each affected brother harbored the MTOR missense alteration p.E1799K (c.5395G>A). This exact variant has been previously identified in multiple independent human somatic cancer samples and has been shown to result in increased MTOR activation. Further, recent independent reports describe two unrelated families in whom p.E1799K co-segregated with megalencephaly and intellectual disability (ID); in both cases, p.E1799K was shown to have originated due to germline mosaicism. In the case of the family reported herein, the absence of p.E1799K in genomic DNA extracted from the blood of either parent suggests that this alteration most likely arose due to gonadal mosaicism. Further, the p.E1799K variant exerts its effect by a gain-of-function (GOF), autosomal dominant mechanism.ConclusionHerein, we describe the use of DES to uncover an activating MTOR missense alteration of gonadal mosaic origin that is likely to be the causative mutation in two brothers who present multiple neurological and developmental abnormalities. Our report brings the total number of families who harbor MTOR p.E1799K in association with megalencephaly and ID to three. In each case, evidence suggests that p.E1799K arose in the affected individuals due to gonadal mosaicism. Thus, MTOR p.E1799K can now be classified as a pathogenic GOF mutation that causes megalencephaly and cognitive impairment in humans.

Smith–Kingsmore Syndrome: A Third Family with the MTOR Mutation C.5395g>a P.(glu1799lys) and Evidence for Paternal Gonadal Mosaicism

A Case of Ichthyosis Follicularis, Atrichia and Photophobia Syndrome Caused by a Novel Mutation in the MBTPS2 Gene

Germline activating MTOR mutation arising through gonadal mosaicism in two brothers with megalencephaly and neurodevelopmental abnormalities

Low‐level Germline Mosaicism of a Novel SMARCA2 Missense Variant: Expanding the Phenotypic Spectrum and Mode of Genetic Transmission

[Genetic Analysis of a Mosaic Case with Low Proportion Mutation of TSC2 Gene].

Identification of Novel KMT2D Mutations in Two Chinese Children with Kabuki Syndrome: a Case Report and Systematic Literature Review

A familial case of Galloway-Mowat syndrome due to a novel TP53RK mutation: a case report

De novo missense variants in RRAGC lead to a fatal mTORopathy of early childhood

The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions

A gonadal mosaicism novel KMT2D mutation identified by haplotype construction and clone sequencing strategy

Specific Mosaic KRAS Mutations Affecting Codon 146 Cause Oculoectodermal Syndrome and Encephalocraniocutaneous Lipomatosis

Expanding the Genetic and Phenotypic Spectrum of Mowat‐Wilson Syndrome: A Study of 10 Turkish Patients With an Intrafamilial Recurrence Caused by First Intragenic Large Deletion

Identification of novel TMEM231 gene splice variants and pathological findings in a fetus with Meckel Syndrome

[Analysis of gene mutation in a family with Muir-Torre syndrome accompanied with extraorbital cystic sebaceous carcinoma]

Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies

Mutations in MKKS cause Bardet-Biedl syndrome

Mutations in PRDM15 Are a Novel Cause of Galloway-Mowat Syndrome.

Multifocal, multiphenotypic tumours arising from an MTOR mutation acquired in early embryogenesis

3M syndrome patient with a novel mutation: A case report

Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy

Potential Pitfalls in Pre-implantation Genetic Diagnosis in a Patient with Tuberous Sclerosis and Isolated Mosaicism for a TSC2 Variant in Renal Tissue